Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. P. Hart
Development of a Wilms' Tumor Antigen-Specific T-Cell Receptor for Clinical Trials: Engineered Patient's T Cells Can Eliminate Autologous Leukemia Blasts in NOD/SCID Mice
Haematologica
Hematology
Related publications
Genetically Engineered T Cells Expressing a HER2-specific Chimeric Receptor Mediate Antigen-Specific Tumor Regression
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Regimen-Specific Effects of RNA-Modified Chimeric Antigen Receptor T Cells in Mice With Advanced Leukemia
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Development of Engineered T Cells Expressing a Chimeric CD16-CD3 Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia
Clinical Cancer Research
Cancer Research
Oncology
768. Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Inducible T-Cell Receptor Expression in Precursor T Cells for Leukemia Control
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Treatment of Advanced Leukemia in Mice With mRNA Engineered T Cells
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Production of Antigen-Specific Suppressive T Cell Factor by Radiation Leukemia Virus-Transformed Suppressor T Cells.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Anti-Car-Engineered T Cells for Epitope-Based Elimination of Autologous CAR T Cells
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
High-Throughput Screening of Human Tumor-Antigen Specific CD4 T Cells, Including Neo-Antigen Reactive T Cells
Clinical Cancer Research
Cancer Research
Oncology
